강남뷰베스트의원강남뷰베스트의원

Ovarian Cancer Screening (ROMA Test)

This is a precision ovarian cancer screening (ROMA test) that measures two tumor markers, CA125 and HE4, simultaneously.

When to ask about Ovarian Cancer Screening (ROMA Test)

If any of these apply to you, this treatment can help. Not sure? Check quickly via AI chat.

  • Women with pelvic masses

    Women with pelvic masses

    Suitable for evaluating the risk of malignancy in a detected pelvic mass.

  • Women with a family history of ovarian cancer

    Women with a family history of ovarian cancer

    Recommended for those who need regular ovarian health monitoring due to family history.

  • Women seeking pre/postmenopausal screening

    Women seeking pre/postmenopausal screening

    Suitable for those who want to accurately check the risk of ovarian cancer based on menopausal status.

PRICING

Curious about the price?

Get pricing and a plan that fits you quickly through AI consultation.

What to look for after Ovarian Cancer Screening (ROMA Test)

See what this treatment can do for you. Results may vary by individual condition.

01 Improved diagnostic accuracy

Combining CA125 and HE4 indicators provides higher sensitivity than a single test.

02 Consideration of menopausal status

Calculates a customized risk index by reflecting the patient's menopausal status in the algorithm.

03 Epithelial ovarian cancer risk assessment

Assists in predicting the risk of epithelial ovarian cancer, which is often difficult to detect early.

Improved diagnostic accuracy

How Ovarian Cancer Screening (ROMA Test) works

How this treatment works.

  1. Ovarian Cancer Screening (ROMA Test) Principle

    The ROMA score is calculated by measuring the levels of two proteins, CA125 and HE4, in the blood and applying a regression equation that includes menopausal status as a variable. HE4 typically does not rise significantly in benign gynecological conditions but increases in epithelial ovarian cancer, thus distinguishing benign from malignant conditions better than CA125 alone.

Please Read Before Treatment

Important points to know for safe treatment. Please review carefully beforehand.

  • Not a definitive diagnosis

    This test is a risk assessment tool; a biopsy is required for a final cancer diagnosis.

  • Influence of benign conditions

    Levels may increase due to benign conditions such as endometriosis or uterine fibroids.

  • Consultation required

    Results must be interpreted by a specialist alongside clinical symptoms and imaging tests.

FAQ

Frequently Asked Questions

Common questions answered. Have more? Just ask via AI chat.

How is it different from the standard CA125 test?

It supplements accuracy by measuring HE4 alongside CA125 to reduce false-positive rates compared to CA125 alone.

Is fasting required before the test?

It is conducted as a standard blood test, and special fasting or prior preparation is generally not required.

If the score is high, does it mean I definitely have cancer?

It only indicates a higher risk; the exact cause must be identified through additional imaging like ultrasound or CT.

Both chief directors personally provide treatment.

Both directors are board-certified OB-GYNs, personally handling everything from consultation to procedures.

Get a Consultation Now

Assessing Ovarian Health with Two Key Markers